InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+43.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Tsai Chen Lung, Director. Director active across 1 company, notably CapsoVision, Inc. In total, 4 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €71. History available since 31 December 2025. The latest transaction was disclosed on 3 July 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Tsai Chen Lung
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
2,022 股Common StockSEC:0001307275-26-000007:0
20 股@ US$4.170.0000% mcap50.0% 占其流量Common StockSEC:0001307275-26-000002:0
标准退出：2025年10月1日 (T+90)
2,887 股@ US$10.6999.7% 占其流量Common StockSEC:0001307275-25-000009:0
91,432 股Common StockSEC:0000950170-25-094309:0
4 条申报中的 4 条
About Tsai Chen Lung
Tsai Chen Lung is a Director at CapsoVision, Inc (XNAS). This insider has 4 filings in total, and among the 4 recent filings held, the buy amount is EUR 71 and the sell amount is EUR 0, over the period from 2025-07-07 to 2026-07-01, with Levée d'options as the most common transaction nature.
